Check out our blogs! CMIC Group is contract research organization supporting companies in pharmaceutical developments.
Over the past decade, checkpoint inhibitors have transformed the landscape [...]
What is an ICCC in Japan? Conducting clinical trials in [...]
Rare diseases, often called “orphan diseases,” affect small patient populations [...]
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting—held [...]
The JP Morgan Healthcare Conference remains one of the most [...]
As the pharmaceutical and biotech sectors advance, Contract Research Organizations [...]
On July 30th, 2024, CMIC Group's COO and President, Keiko [...]
Decentralized clinical trials (DCTs) and Virtual Clinical Trials (VCTs) have [...]
Entering the Japanese pharmaceutical market presents a lucrative opportunity for [...]
In the ever-evolving landscape of healthcare, drug pricing and availability [...]
Rare Disease Day, observed on the last day of February [...]
As we step into 2024, the healthcare industry is undergoing [...]
The Asia-Pacific (APAC) region has continued to thrive as a [...]
This year marked the return of The Summit for Clinical [...]
Japan has spent the last year and a half battling [...]
© CMIC HOLDINGS Co., LTD. All rights reserved.
Never miss an update – Click below to receive emails on CMIC‘s global services, latest news, & more!
Click Here to Sign Up
